HomePTX • ASX
add
Prescient Therapeutics Ltd
Nakaraang pagsara
$0.052
Sakop ng araw
$0.051 - $0.054
Sakop ng taon
$0.040 - $0.13
Market cap
55.77M AUD
Average na Volume
797.49K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 578.89K | -7.26% |
Gastos sa pagpapatakbo | 2.57M | 33.16% |
Net na kita | -1.99M | -62.79% |
Net profit margin | -344.35 | -75.54% |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 9.77M | 16.21% |
Kabuuang asset | 18.48M | 11.46% |
Kabuuang sagutin | 1.51M | 61.48% |
Kabuuang equity | 16.97M | — |
Natitirang share | 1.05B | — |
Presyo para makapag-book | 2.60 | — |
Return on assets | -26.94% | — |
Return on capital | -28.87% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.99M | -62.79% |
Cash mula sa mga operasyon | -3.27M | -13.02% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 4.69M | 3,268.72% |
Net change in cash | 1.42M | 169.16% |
Malayang cash flow | -1.04M | -29.50% |
Tungkol
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
Itinatag
May 22, 1986
Website
Mga Empleyado
3
